Clinical Trial

Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This Phase III Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-08-04
notable Enrollment increased: 180 -> 240 participants 2026-08-04
minor Completion pushed: 2028-04-28 -> 2028-06-09 2026-08-04
Trial Details
NCT Number NCT07402213
Lead Sponsor Jemincare
Conditions Chronic Spontaneous Urticaria
Enrollment 240 participants
Start Date 2026-03-09
Primary Completion 2027-06-07 (estimated)
Study Completion 2028-06-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-03